EDITAS MEDICINE, INC. Other Comprehensive Income (Loss), Net of Tax
EDITAS MEDICINE, INC. (EDIT) reported Other Comprehensive Income (Loss), Net of Tax of -$6.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-08-02
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-06-30 was -$6.00K.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-03-31 was $1.32M.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for the quarter ending 2022-09-30 was -$904.00K, a 13014.29% decline year-over-year.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for the quarter ending 2022-06-30 was -$878.00K, a 44000.00% decline year-over-year.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$3.11M.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$447.00K.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$153.00K, a 212.50% decline from fiscal 2019.
- EDITAS MEDICINE, INC. other comprehensive income (loss), net of tax for fiscal 2019 was $136.00K, a 189.36% increase from fiscal 2018.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$6.00K 10-Q · filed 2023-08-02 | $1.32M derived: sum of 2 quarters · filed 2023-08-02 | ||
| 2023-03-31 | $1.32M 10-Q · filed 2023-08-02 | |||
| 2022-12-31 | -$3.11M 10-K · filed 2023-02-22 | |||
| 2022-09-30 | -$904.00K 10-Q · filed 2022-11-02 | -$1.78M derived: sum of 2 quarters · filed 2023-08-02 | -$3.80M derived: sum of 3 quarters · filed 2023-08-02 | |
| 2022-06-30 | -$878.00K 10-Q · filed 2023-08-02 | -$2.89M derived: sum of 2 quarters · filed 2023-08-02 | ||
| 2022-03-31 | -$2.02M 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | -$447.00K 10-K · filed 2023-02-22 | |||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-02 | $9.00K derived: sum of 2 quarters · filed 2022-11-02 | -$18.00K derived: sum of 3 quarters · filed 2022-11-02 | |
| 2021-06-30 | $2.00K 10-Q · filed 2022-11-02 | -$25.00K derived: sum of 2 quarters · filed 2022-11-02 | ||
| 2021-03-31 | -$27.00K 10-Q · filed 2022-11-02 | |||
| 2020-12-31 | -$153.00K 10-K · filed 2023-02-22 | |||
| 2020-09-30 | -$231.00K 10-Q · filed 2021-11-09 | -$742.00K derived: sum of 2 quarters · filed 2021-11-09 | -$155.00K derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$511.00K 10-Q · filed 2021-11-09 | $76.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $587.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $136.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$6.00K 10-Q · filed 2020-11-06 | $10.00K derived: sum of 2 quarters · filed 2020-11-06 | $68.00K derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $16.00K 10-Q · filed 2020-11-06 | $74.00K derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $58.00K 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $47.00K 10-K · filed 2021-02-26 | |||
| 2018-09-30 | -$83.00K 10-Q · filed 2019-11-12 | -$30.00K derived: sum of 2 quarters · filed 2019-11-12 | -$6.00K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | $53.00K 10-Q · filed 2019-11-12 | $77.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | $24.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$76.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |